AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
AIM vs ARMP Fundamental Comparison
| Metric | AIM | ARMP |
|---|---|---|
| Revenue | $22,000.0 | $31,000.0 |
| Net Income | $-3.0M | $-115.3M |
| Net Margin | -13,740.9% | -372,083.9% |
| ROE | -142.3% | N/A |
| ROA | -35.2% | -165.3% |
| Current Ratio | 1.01x | 0.64x |
| Debt/Equity | 1.98x | N/A |
| EPS | $-0.69 | $-3.16 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
AIM vs ARMP: Frequently Asked Questions
Is AIM or ARMP the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. AIM is graded D (96% confidence) while ARMP is graded D (96% confidence). This is not investment advice.
How does AIM compare to ARMP fundamentally?
AIM ImmunoTech Inc. has ROE of -142.3% vs Armata Pharmaceuticals, Inc.'s N/A. Net margins are -13,740.9% vs -372,083.9% respectively.
Which stock pays higher dividends, AIM or ARMP?
AIM has a dividend yield of N/A or no dividend while ARMP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in AIM or ARMP for long term?
For long-term investing, consider that AIM has a D grade with 96% confidence, while ARMP has a D grade with 96% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about AIM vs ARMP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For AIM vs ARMP, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.